PT-141
Also known as: Bremelanotide
PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist derived from Melanotan II. It is FDA-approved as Vyleesi (2019) for hypoactive sexual desire disorder in premenopausal women only.
Pricing for PT-141
Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.
COAs for PT-141
71 third-party tests across 21 vendors. Each card links to the full report.
For
PT-141
by EZ Peptides· batch EZP-PT1005172026-08
For
PT-141
by Crush Research· batch CRPT-10-2605-1
For
PT-141
by Verified Peptides· batch PT03261310J
For
PT-141
by Real Peptides· batch White Cap
For
PT-141
by Verified Peptides· batch cmpds11k4002104l7jqg8dx52
For
PT-141
by Skye Peptides· batch PT26-10-002
For
PT-141
by BioLongevity Labs· batch 25-3-43136
For
PT-141
by IDUN Peptides· batch PT10-260331
For
PT-141
by NG Peptide· batch PT10-1639
For
PT-141
by Peptidegurus· batch 24th Feb 2026
For
PT-141
by Peptide Plugs· batch 112-U
For
PT-141
by Qihang Peptide· batch 4
For
PT-141
by Amino Club· batch PT0001
For
PT-141
by Ion Peptide· batch PT141-04022026
For
PT-141
by Mile High Compounds· batch PT1-010-MH-02
For
PT-141
by Glacier Aminos· batch PT10GA-02
For
PT-141
by Verified Peptides· batch PT03261310J
For
PT-141
by Peptide Supply Co.· batch PSCPT410001
For
PT-141
by Ascension Peptides· batch 28-01260229
For
Bremelanotide
by Ascension Peptides· batch 28-01260229
For
PT-141
by BioLongevity Labs· batch 25-3-46035
For
PT-141
by Skye Peptides· batch PT26-10-001
For
PT-141
by BioLongevity Labs· batch QC260247
For
PT141
by Verified Peptides· batch PT01261210I
17 citations indexed for PT-141
Study · 2026
Evaluation of Research Grade Peptides Marketed Directly to Consumers Reveals Extensive Variability in Purity and Measured Abundance
Peptides are a rapidly expanding drug class with a parallel and largely unregulated gray market that sells preparations directly to consumers for self-administration.
review · 2026
Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives
Therapeutic peptides are short chains of amino acids used to treat metabolic and endocrine conditions such as obesity and type 2 diabetes.
review · 2026
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging
Background Peptide therapeutics represent an emerging frontier in gerontological medicine, targeting fundamental hallmarks of aging including metabolic dysfunction, telomere attrition, tissue repair impairment, and hormonal decline.
Study · 2026
Injuries, Injections, and Internet Forums: A Qualitative Study of Reddit User Perspectives on Peptide Therapy After Orthopaedic Surgery
review · 2025
Intravenous peptides and amino acids for erectile dysfunction: a narrative review of current applications and future directions
Introduction Erectile dysfunction (ED) pathophysiology involves complex interactions between vasculogenic, hormonal, and neurological mechanisms, with endothelial dysfunction and oxidative stress playing crucial roles.
Study · 2024
A multimodal fusion network based on a cross-attention mechanism for the classification of Parkinsonian tremor and essential tremor
Parkinsonian tremor (PT) and Essential tremor (ET) exist as upper limb tremors in clinical practice. Notably, their types of trembling share similar presentations and overlapping frequencies.